1. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial. Issue 4 (31st October 2013) Authors: Denison, H.; Nilsson, C.; Löfgren, L.; Himmelmann, A.; Mårtensson, G.; Knutsson, M.; AL‐Shurbaji, A.; Tornqvist, H.; Eriksson, J. W. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 4(2014:Apr.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗